glp-1/gip peptide GLP1 GIP 5mg GIP (Gastric Inhibitory Polypeptide) Assay

Response rates vary by molecule newer agents such as tirzepatide and semaglutide yield higher responder rates (~86%91%) than older agents such as exenatide or liraglutide (~40%65%) (223) and vary by baseline BMI, sex, and glycemic status, with women and individuals with higher BMI responding better (222, 224)

Hold for 30 to 60 seconds and perform two or three times per side

But there are differences depending on which one youre taking

Apr 3, 2025 S4.E8: My Life on GLP-1: Break Free from your Stall or Plateau Stuck in a weight loss stall on Mounjaro or Zepbound

Exenatide The FDA OKd exenatide in 2005, making it the first approved GLP-1 for Type 2 diabetes